Welcome to our dedicated page for Neon Bloom news (Ticker: NBCO), a resource for investors and traders seeking the latest updates and insights on Neon Bloom stock.
Neon Bloom, Inc. reports developments tied to its OTC-traded operating company status and its current focus on financial technology through Advanced Executive Sales, its payment-processing subsidiary. Recurring news themes include electronic payment and card-processing platforms, e-commerce and point-of-sale transaction solutions, software integrations, business-development relationships, and efforts to reduce fraud, chargebacks, and third-party vendor dependence.
The company’s recent corporate history also includes the completed acquisition of Advanced Executive Sales and the divestment of Bazelet Health Systems, marking a shift away from HealthTech and toward financial services, software-enabled payments, and related acquisition activity.
Neon Bloom, Inc. (OTC: NBCO) announced on April 16, 2021, that Bazelet Oglesby has successfully planted its patented 0.00% THC Panakeia cannabis plants in South Georgia. This development marks Bazelet's entry into the Georgia cannabis market, utilizing a former golf course for crop production. Panakeia is the world's first patented cannabis plant with zero THC, making it compliant with federal law. Bazelet aims to provide safe and effective cannabinoid products for healthcare professionals, particularly as Georgia launches a low THC medical marijuana program.
Bazelet Health Systems, a subsidiary of Neon Bloom, Inc. (OTC: NBCO), has appointed Dr. Francisco Ward as its new Chief Medical Officer. Dr. Ward, a graduate of Johns Hopkins School of Medicine, brings over 25 years of medical expertise and leadership, particularly in the endocannabinoid system and medical cannabis. He is tasked with overseeing Bazelet's healthcare programs, clinical research, and patient experience standards from the Columbia, Maryland office. His appointment emphasizes Bazelet's commitment to effective medical treatment through advanced research and patient-centered care.
Neon Bloom, Inc. (OTC: NBCO) announces the formation of Bazelet Oglesby, LLC, a partnership with Oglesby Plants International, Inc. to develop THC/CBD-free cannabis varieties. This strategic alliance aims to advance the commercialization of cannabis for food, beverage, OTC, and pharmaceutical applications. Operated from Florida, Bazelet Oglesby boasts over $4M in recent capital improvements and a team of horticultural specialists focused on creating elite cannabis strains intended to enhance market demand for plant-derived products. This initiative positions NBCO as a leader in the sustainable cannabis industry.
Neon Bloom, Inc. (OTC: NBCO) has completed the acquisition of Bazelet Health Systems, Inc. in an all-stock deal involving 120 million shares. This acquisition positions Neon Bloom at the forefront of the cannabis industry, focusing on THC-free cannabis and genome engineering. Bazelet operates three subsidiaries: Bazelet Oglesby for plant science, Bazelet Research for CRISPR-Cas9 technologies, and Bazelet Learning for cannabis education. Co-founders Michael Clinton and David Grand emphasized the strategic importance and potential value this acquisition brings to shareholders.